1 |
Rauso R, Salti G. A CE-marked drug used for localized adiposity reduction: a 4-year experience. Aesthet Surg J 2015;35(07):850-857
DOI
|
2 |
Sykes JM, Allak A, Klink B. Future applications of deoxycholic acid in body contouring. J Drugs Dermatol 2017;16(01):43-46
|
3 |
Pinto H, Hernandez C, Turra C, Manzano M, Salvador L, Tejero P. Evaluation of a new adipocytolytic solution: adverse effects and their relationship with the number of vials injected. J Drugs Dermatol 2014;13(12):1451-1455
|
4 |
Shridharani SM. Injection of an adipocytolytic agent for reduction of excess periaxillary fat. Aesthet Surg J 2019;39(12):NP495-NP503
DOI
|
5 |
Liu M, Chesnut C, Lask G. Overview of Kybella (deoxycholic acid injection) as a fat resorption product for submental fat. Facial Plast Surg 2019;35(03):274-277
DOI
|
6 |
Lindsey SF, Benesh G, Pavlis J, Zaiac M. Deoxycholic acid injections for the treatment of infraorbital fat pads. Dermatol Surg 2019;45(12):1720-1723
DOI
|
7 |
Dayan SH, Humphrey S, Jones DH, et al. Overview of ATX-101 (deoxycholic acid injection): a nonsurgical approach for reduction of submental fat. Dermatol Surg 2016;42(01, Suppl 1):S263-S270
DOI
|
8 |
Sung CT, Lee A, Choi F, Juhasz M, Mesinkovska NA. Non-submental applications of injectable deoxycholic acid: a systematic review. J Drugs Dermatol 2019;18(07):675-680
|
9 |
Di Toro G, Rauso R. Skin necrosis following adipocitolitic solution injections. Aesthet Surg J 2016;36(02):NP74-NP76
DOI
|
10 |
Lindgren AL, Welsh KM. Inadvertent intra-arterial injection of deoxycholic acid: a case report and proposed protocol for treatment. J Cosmet Dermatol 2020;19(07):1614-1618
DOI
|
11 |
Grady B, Porphirio F, Rokhsar C. Submental alopecia at deoxycholic acid injection site. Dermatol Surg 2017;43(08):1105-1108
DOI
|
12 |
Riswold K, Flynn V. A cautionary tale: a vascular event with deoxycholic acid injection. Dermatol Surg 2018;44(06):887-889
DOI
|
13 |
Sachdev D, Mohammadi T, Fabi SG. Deoxycholic acid-induced skin necrosis: prevention and management. Dermatol Surg 2018;44(07):1037-1039
DOI
|
14 |
Save Face. Laws and Regulations of the Non-surgical Cosmetic Industry. Accessed April 9, 2022 at: https://www.saveface.co.-uk/laws-regulations-non-surgical-cosmetic-industry/
|
15 |
Humphrey S, Sykes J, Kantor J, et al. ATX-101 for reduction of submental fat: a phase III randomized controlled trial. J Am Acad Dermatol 2016;75(04):788-797
DOI
|
16 |
Behr K, Kavali CM, Munavalli G, et al. ATX-101 (deoxycholic acid injection) leads to clinically meaningful improvement in submental fat: final data from CONTOUR. Dermatol Surg 2020;46(05):639-645
DOI
|
17 |
Rauso R, Rusciani A, Curinga G. An adipocitolitic aqueous micro-gelatinous solution for buffalo hump deformity reduction. J Drugs Dermatol 2014;13(10):1282-1284
|
18 |
Rittes PG. The use of phosphatidylcholine for correction of lower lid bulging due to prominent fat pads. Dermatol Surg 2001;27(04):391-392
|
19 |
Souyoul S, Gioe O, Emerson A, Hooper DO. Alopecia after injection of ATX-101 for reduction of submental fat. JAAD Case Rep 2017;3(03):250-252
DOI
|
20 |
Fagien S, McChesney P, Subramanian M, Jones DH. Prevention and management of injection-related adverse effects in facial aesthetics: considerations for ATX-101 (deoxycholic acid injection) treatment. Dermatol Surg 2016;42(01, Suppl 1):S300-S304
DOI
|
21 |
Humphrey S, Femmer P, Beleznay K, Carruthers JDA. Deoxycholic acid for submental fullness and more: real-world experience with 202 patients. Dermatol Surg 2019;45(04):624-627
DOI
|
22 |
Rotunda AM, Suzuki H, Moy RL, Kolodney MS. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg 2004;30(07):1001-1008
|